T1	Outcomes 0 41	Pharmacokinetic-pharmacodynamic modelling
T2	Outcomes 114 149	pharmacokinetic and pharmacodynamic
T3	Outcomes 692 715	pharmacokinetic profile
T4	Outcomes 783 806	concentration-time data
T5	Outcomes 909 930	Plasma concentrations
T6	Outcomes 1214 1245	typical pharmacokinetic profile
T7	Outcomes 1371 1400	pharmacodynamic relationships
T8	Outcomes 1434 1466	bilastine plasma concentrations.
T9	Outcomes 1495 1546	concentration that produced 50% inhibition (IC(50))
T10	Outcomes 1635 1656	plasma concentrations
T11	Outcomes 1977 2003	plasma peak concentrations
T12	Outcomes 2061 2077	maximal response
T13	Outcomes 2272 2314	inhibitory bilastine plasma concentrations
T14	Outcomes 2333 2356	input response function
T15	Outcomes 2554 2629	apparent zero-order rate constant for flare or wheal spontaneous appearance
T16	Outcomes 2643 2701	first-order rate constant for flare or wheal disappearance
T17	Outcomes 2715 2738	bilastine IC(50) values
T18	Outcomes 2992 3023	bilastine plasma concentrations
T19	Outcomes 3191 3212	plasma concentrations
